These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065 [TBL] [Abstract][Full Text] [Related]
24. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Ye S; Dhillon S; Turner SJ; Bateman AC; Theaker JM; Pickering RM; Day I; Howell WM Cancer Res; 2001 Feb; 61(4):1296-8. PubMed ID: 11245423 [TBL] [Abstract][Full Text] [Related]
25. Involvement of chromosome losses in the progression and metastasis formation of a human malignant melanoma. Balázs M; Adám Z; Bégány A; Takruri AT; Adány R Cancer Genet Cytogenet; 1999 Mar; 109(2):114-8. PubMed ID: 10087942 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Stark M; Hayward N Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583 [TBL] [Abstract][Full Text] [Related]
32. Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage. Talve L; Sauroja I; Collan Y; Punnonen K; Ekfors T Int J Cancer; 1997 Jun; 74(3):255-9. PubMed ID: 9221801 [TBL] [Abstract][Full Text] [Related]
33. Oncogenes in melanoma: an update. Kunz M Eur J Cell Biol; 2014; 93(1-2):1-10. PubMed ID: 24468268 [TBL] [Abstract][Full Text] [Related]
34. Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics. Poetsch M; Woenckhaus C; Dittberner T; Pambor M; Lorenz G; Herrmann FH Lab Invest; 1998 Jul; 78(7):883-8. PubMed ID: 9690566 [TBL] [Abstract][Full Text] [Related]
35. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin. Poetsch M; Dittberner T; Cowell JK; Woenckhaus C Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369 [TBL] [Abstract][Full Text] [Related]
37. Update on genetic events in the pathogenesis of melanoma. Halachmi S; Gilchrest BA Curr Opin Oncol; 2001 Mar; 13(2):129-36. PubMed ID: 11224711 [TBL] [Abstract][Full Text] [Related]
38. Molecular aspects of malignant melanoma. Role of protooncogenes and oncosuppressor genes. Kremen J; Stríbrná J; Pohlreich P; Hradecký P Sb Lek; 1994; 95(4):321-31. PubMed ID: 8867703 [TBL] [Abstract][Full Text] [Related]
39. [Genetic principles of malignant transformation]. Maly K Acta Med Austriaca; 1992; 19(4):91-5. PubMed ID: 1290321 [TBL] [Abstract][Full Text] [Related]
40. Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma. Wagner SN; Wagner C; Briedigkeit L; Goos M Br J Dermatol; 1998 Jan; 138(1):13-21. PubMed ID: 9536218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]